How Will the Controlled Release Drug Delivery Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Will the Controlled Release Drug Delivery Market Grow Over the Forecast Period Based on Its Expected CAGR?
The market size of the controlled release drug delivery has seen significant expansion in the preceding years. The market, which was valued at $65.44 billion in 2024, is predicted to swell to $73.01 billion in 2025, displaying a compound annual growth rate (CAGR) of 11.6%. The notable growth witnessed in the past period can be linked to the advent of innovative drug delivery systems, initial polymer-based recipes, the introduction of microencapsulation processes, the rise of transdermal delivery, the granting of regulatory permits, and standardization efforts.
The market size of controlled release drug delivery is predicted to undergo swift expansion in the forthcoming years. The growth is projected to hit $119.41 billion in 2029, with a compound annual growth rate (CAGR) of 13.1%. Factors contributing to this growth during the forecast period include the movement towards personalized medicine, the assimilation of technology for the benefit of patients, the broadening scope of biologics and biosimilars, market stretching in emerging regions, and polymer science advancements. Significant trends in the forecast timeframe are likely to encompass degradable and compatible materials, progress in nanotechnology, personalized medicine & targeted therapies, improvements in implantable devices, and innovative methods of encapsulation.
What Factors Are Propelling the Growth of the controlled release drug delivery Market from 2025 to 2034?
The increasing occurrence of chronic or noncommunicable afflictions such as heart disease, cancer, and diabetes is believed to drive the expansion of the controlled release drug delivery market. These are health conditions that persist over a year, necessitate ongoing medical attention, and often impose limitations on an individual’s routine activities. The role of controlled-release drug delivery is pivotal for the effective treatment of these illnesses. For patients suffering from chronic diseases needing long-term care, or those living in areas with inadequate healthcare facilities, medication delivery methods facilitating prolonged release of drugs are indispensable. As per a report in September 2022 by the World Health Organization (WHO), a health-specialized entity based in Switzerland, chronic diseases claim the lives of 41 million individuals annually, making up 74% of all global deaths. Tragically, 17 million people succumb to such health problems before they reach their seventieth birthday. Alarmingly, most of these deaths, 77% to be precise, take place in low-income and middle-income countries. The statistics are anticipated to surge in the future. Consequently, the increasing prevalence of chronic diseases is fuelling the growth of the controlled release drug delivery market.
Explore Comprehensive Insights Into The Global Controlled Release Drug Delivery Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp
Who Are the Dominant Players Expanding Their Reach in the Controlled Release Drug Delivery Market?
Major companies operating in the controlled release drug delivery market include:
• Johnson & Johnson Services Inc._x000D_
• Merck & Co. Inc._x000D_
• Alkermes plc_x000D_
• Coating Place Inc._x000D_
• Corium International Inc._x000D_
What Are the Top Trends Shaping the Evolution of the Controlled Release Drug Delivery Market?
In the controlled-release drug delivery market, one significant trend that is increasingly being observed is the technological evolution. To retain their market positions, large firms in this field are embracing innovative technologies. For instance, in March 2022, a pharmaceutical company based in Germany, Evonik Industries AG, unveiled a revolutionary microparticle technology, UDRATEC SoluFlow, aimed at augmenting the solubility of active medicinal ingredients in orally administered drugs. This technique of emulsion-based processing surpasses solubility issues that conventional manufacturing methods fail to overcome. Adding to their suite of oral drug delivery solutions, EUDRATEC SoluFlow complements Evonik Health Care’s product lineup which features oral excipients such as EUDRAGIT functional polymers, pre-ready functional capsules like EUDRACAPTM, and more technologies and services to enhance medication effectiveness.
Secure Your Global Controlled Release Drug Delivery Market Report Now for Fast and Efficient Delivery!
Which Market Segments Are Driving Strategic Growth and Trends in the Controlled Release Drug Delivery Market?
The controlled release drug delivery market covered in this report is segmented –
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems
Which Regions Are Setting the Pace for Controlled Release Drug Delivery Market Growth?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Is the Controlled Release Drug Delivery Market Defined Across Different Regions?
Controlled release drug delivery refers to a dosage form that administers a medicine or medication in a specified way. This drug delivery method continuously delivers pharmaceuticals or medications in predictable kinetics for the predetermined time.
Browse Through More Similar Reports By The Business Research Company:
Drugs For Erectile Dysfunction Global Market Report 2024
Drugs For Hormonal Replacement Therapy Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
